Overview

Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of ramelteon, once daily (QD), in individuals with obstructive sleep apnea.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda